Access cutting-edge melanoma treatment through this clinical trial at a research site in Fairbanks. Study-provided care at no cost to qualified participants.
Access melanoma specialists in Fairbanks at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
This phase II trial investigates how well biomarkers on PET/CT imaging drive early discontinuation of anti-PD-1 therapy in patients with stage IIIB-IV melanoma that cannot be removed by surgery (unresectable). Anti-PD-1 therapy has become a standard therapy option for patients with unresectable melanoma. This trial is being done to determine if doctors can safely shorten the use of standard of care anti-PD1 therapy for melanoma by using biomarkers seen on PET/CT imaging and tumor biopsy.
Sponsor: ECOG-ACRIN Cancer Research Group
Check if you qualify for this melanoma clinical trial in Fairbanks, AK
If you're searching for melanoma treatment options in Fairbanks, AK, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fairbanks research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.